CNBC Daily Open: Wall Street rebound fizzles out
Wall Street’s comeback attempt fizzles out. JPMorgan’s Jamie Dimon sees recession ahead. Warner Bros. sinks on $9.1 billion write-down.
Asia markets mixed as Wall Street recovery stalls; investors assess Japan trade data
Japan’s current account surplus for June came in at 1.533 trillion yen, lower than the 1.789 trillion yen expected by economists polled by Reuters.
China will have nearly twice as many pets as young children by 2030, Goldman Sachs says
The country’s urban pet population is set to hit over 70 million by the end of the decade, while the number of children under the age of four will dwindle to less than 40 million.
China’s exporters enjoyed the benefits of a weak yuan. Now that’s changing and cutting into profits
Chinese companies seeking growth from exports face a new challenge: a strengthening yuan.
The S&P 500 made big swings this week. Here’s how stocks usually trade in August
To some investors, the big moves moves week shouldn’t come as a surprise.
Morgan Stanley names a ‘defensive’ and cheap Taiwanese AI stock to own amid volatility
One Taiwanese stock has everything going for it — it’s not just a defensive play amid recent market choppiness, but it’s also an AI trade, Morgan Stanley says.
‘Mag 7’ stocks are cheap and a buy after sell-off as long as no recession, Morgan Stanley says
This week’s steep sell-off in the market’s reigning technology leaders could be a buying opportunity for investors, according to Morgan Stanley.
Ether pulls back again following slight rebound with other risk assets: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry….
These high-dividend-yielding stocks could see a rebound as rates decline, BMO says
These dividend stocks are poised to move higher after the Federal Reserve starts cutting rates, says BMO.
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
Novo Nordisk saw price pressure for its GLP-1 drugs Ozempic and Wegovy. Investors want to know how Eli Lilly’s Zepbound performed.
